#USA #New York #Pomerantz LLP #Surgery Partners #SGRY

Pomerantz Law Firm Investigates Claims on Behalf of Surgery Partners Investors

Pomerantz LLP, a distinguished law firm based in New York, is actively investigating claims on behalf of investors in Surgery Partners, Inc. (NASDAQ: SGRY). This investigation arises amid concerns that the company, as well as some of its executives and directors, may have engaged in potentially unlawful business practices or securities fraud. Investors who believe they have been affected are strongly encouraged to contact Danielle Peyton at Pomerantz to discuss joining the ongoing class action.

Recent Corporate Developments

On November 10, 2025, Surgery Partners released its financial results for the third quarter of the year. During this announcement, the company significantly revised its financial outlook for the year. They adjusted their revenue guidance downward to a range between $3.275 billion and $3.3 billion. Furthermore, the adjusted EBITDA guidance was also lowered to between $535 million and $540 million. This downward revision was cited as a result of delays in capital expenditure, losses related to the divestiture of ambulatory surgical centers, and a cautious forecast regarding the volume of patients covered by commercial payers in the fourth quarter.

This disappointing news had an immediate adverse effect on shareholder value. On the day of the announcement, Surgery Partners' stock plummeted by $5.47 per share, equating to a dramatic decline of 25.42%, ultimately closing at $16.04 per share.

Background on Pomerantz LLP

Founded by the pioneering attorney Abraham L. Pomerantz, who is considered a founding figure in the class action field, Pomerantz LLP has established a reputation for fighting on behalf of victims of securities fraud and corporate misconduct. The firm has a strong track record of recovering millions of dollars for shareholders affected by unethical practices. With offices spread across major cities, including Chicago, Los Angeles, London, and Tel Aviv, they continue their advocacy for transparency and fairness in corporate governance.

Call to Action for Affected Investors

If you are an investor in Surgery Partners and feel that you have suffered losses due to the company’s actions or management decisions, you may want to engage with Pomerantz LLP. Danielle Peyton can be reached through the firm’s contact numbers.

This investigation underscores the importance of maintaining ethical business practices within corporations, particularly as they pertain to investor relations and financial reporting. As the situation unfolds, additional disclosures from Surgery Partners may shed light on the nature of the issues prompting this investigation.

Conclusion

The inquiry by Pomerantz LLP represents a crucial step for affected investors seeking accountability from Surgery Partners. This case exemplifies the broader implications of corporate governance failures and the essential role legal firms play in protecting shareholders' interests. Those impacted are encouraged to seek legal counsel promptly to explore their options as this situation continues to develop.